Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease have?
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease has 99 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease published?
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease has 2018 year in the ScholarIQ index.
What is the open-access status of Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease?
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease has green oa status in the ScholarIQ index.
What is the DOI of Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease?
The DOI for Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease is on the source record.
What is the PMID of Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease?
The PMID for Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease is on the source record.
What is the OpenAlex record for Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease?
The OpenAlex for Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease is on the source record.